Cargando…
Infantile Metachromatic Leukodystrophy (MLD): A Rare Case
Metachromatic leukodystrophy (MLD) is the typical white matter disease belonging to the lysosomal sphingolipid storage group and is a genetic autosomal recessive disorder. Early presentation is in the form of learning disability and behavioral issues; the subsequent involvement is gait and balance....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885241/ https://www.ncbi.nlm.nih.gov/pubmed/36726906 http://dx.doi.org/10.7759/cureus.33155 |
_version_ | 1784879892542783488 |
---|---|
author | Gajbhiye, Varsha Lamture, Yashwant Uke, Punam |
author_facet | Gajbhiye, Varsha Lamture, Yashwant Uke, Punam |
author_sort | Gajbhiye, Varsha |
collection | PubMed |
description | Metachromatic leukodystrophy (MLD) is the typical white matter disease belonging to the lysosomal sphingolipid storage group and is a genetic autosomal recessive disorder. Early presentation is in the form of learning disability and behavioral issues; the subsequent involvement is gait and balance. Prenatal blood testing for genetic screening is available for arylsulfatase A (ARSA) deficiency is indicated if the family history is positive for MLD. Diagnostic tools for MLD are- absence or low-level arylsulfatase activity in genetic screening, sulphatides in urine, and magnetic resonance image (MRI) showing frontal horns and atrial periventricular leukodystrophy. The typical finding is known as the trigonid pattern. A two and half-year-old boy was born out of marriage in near blood relation. No prenatal screening was done. As narrated by the mother, the patient was alright six months back when he gradually developed lower limb weakness. Due to this, he stopped walking, which he could initially do without support. The parent also complained that he used to speak fifteen to twenty words, and now he is not saying a single word. With the above complaint, the patient was taken to the local hospital, where an MRI showed periventricular leukodystrophy, suggesting metachromatic leukodystrophy of periventricular white matter. The practice of prenatal and newborn genetic screening could enhance the efficacy of management, as early interventions are more effective. |
format | Online Article Text |
id | pubmed-9885241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-98852412023-01-31 Infantile Metachromatic Leukodystrophy (MLD): A Rare Case Gajbhiye, Varsha Lamture, Yashwant Uke, Punam Cureus Neurology Metachromatic leukodystrophy (MLD) is the typical white matter disease belonging to the lysosomal sphingolipid storage group and is a genetic autosomal recessive disorder. Early presentation is in the form of learning disability and behavioral issues; the subsequent involvement is gait and balance. Prenatal blood testing for genetic screening is available for arylsulfatase A (ARSA) deficiency is indicated if the family history is positive for MLD. Diagnostic tools for MLD are- absence or low-level arylsulfatase activity in genetic screening, sulphatides in urine, and magnetic resonance image (MRI) showing frontal horns and atrial periventricular leukodystrophy. The typical finding is known as the trigonid pattern. A two and half-year-old boy was born out of marriage in near blood relation. No prenatal screening was done. As narrated by the mother, the patient was alright six months back when he gradually developed lower limb weakness. Due to this, he stopped walking, which he could initially do without support. The parent also complained that he used to speak fifteen to twenty words, and now he is not saying a single word. With the above complaint, the patient was taken to the local hospital, where an MRI showed periventricular leukodystrophy, suggesting metachromatic leukodystrophy of periventricular white matter. The practice of prenatal and newborn genetic screening could enhance the efficacy of management, as early interventions are more effective. Cureus 2022-12-31 /pmc/articles/PMC9885241/ /pubmed/36726906 http://dx.doi.org/10.7759/cureus.33155 Text en Copyright © 2022, Gajbhiye et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Gajbhiye, Varsha Lamture, Yashwant Uke, Punam Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title | Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title_full | Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title_fullStr | Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title_full_unstemmed | Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title_short | Infantile Metachromatic Leukodystrophy (MLD): A Rare Case |
title_sort | infantile metachromatic leukodystrophy (mld): a rare case |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885241/ https://www.ncbi.nlm.nih.gov/pubmed/36726906 http://dx.doi.org/10.7759/cureus.33155 |
work_keys_str_mv | AT gajbhiyevarsha infantilemetachromaticleukodystrophymldararecase AT lamtureyashwant infantilemetachromaticleukodystrophymldararecase AT ukepunam infantilemetachromaticleukodystrophymldararecase |